Detalles de la búsqueda
1.
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC.
Int J Mol Sci
; 24(17)2023 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685884
2.
Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition.
Int J Mol Sci
; 21(8)2020 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32325863
3.
DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
BJU Int
; 118(1): 102-11, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26216234
4.
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
Acta Oncol
; 53(7): 939-44, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24456504
5.
A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
Oncologist
; 17(9): 1146-54, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22711751
6.
Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score.
Sci Rep
; 12(1): 21019, 2022 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36471093
7.
Metal artefact reduction for accurate tumour delineation in radiotherapy.
Radiother Oncol
; 126(3): 479-486, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29050958
8.
Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 6: e2200040, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35797511
9.
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
Lung Cancer
; 113: 14-17, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29110841
10.
Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
BMC Res Notes
; 6: 489, 2013 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24279718
Resultados
1 -
10
de 10
1
Próxima >
>>